202 related articles for article (PubMed ID: 24034279)
1. ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylase.
Hofland J; Hofland LJ; van Koetsveld PM; Steenbergen J; de Herder WW; van Eijck CH; de Krijger RR; van Nederveen FH; van Aken MO; de Groot JW; Links TP; de Jong FH; Feelders RA
Orphanet J Rare Dis; 2013 Sep; 8():142. PubMed ID: 24034279
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome.
de Groot JW; Links TP; Themmen AP; Looijenga LH; de Krijger RR; van Koetsveld PM; Hofland J; van den Berg G; Hofland LJ; Feelders RA
Eur J Endocrinol; 2010 Aug; 163(2):293-9. PubMed ID: 20460422
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
Bertherat J; Contesse V; Louiset E; Barrande G; Duparc C; Groussin L; Emy P; Bertagna X; Kuhn JM; Vaudry H; Lefebvre H
J Clin Endocrinol Metab; 2005 Mar; 90(3):1302-10. PubMed ID: 15585558
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.
Mazzuco TL; Thomas M; Martinie M; Cherradi N; Sturm N; Feige JJ; Chabre O
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1452-62. PubMed ID: 18209887
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia.
Daidoh H; Morita H; Hanafusa J; Mune T; Murase H; Sato M; Shibata T; Suwa T; Ishizuka T; Yasuda K
Clin Endocrinol (Oxf); 1998 Sep; 49(3):403-9. PubMed ID: 9861334
[TBL] [Abstract][Full Text] [Related]
7. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Mune T; Murase H; Yamakita N; Fukuda T; Murayama M; Miura A; Suwa T; Hanafusa J; Daido H; Morita H; Yasuda K
J Clin Endocrinol Metab; 2002 Dec; 87(12):5706-13. PubMed ID: 12466375
[TBL] [Abstract][Full Text] [Related]
8. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
Miyamura N; Taguchi T; Murata Y; Taketa K; Iwashita S; Matsumoto K; Nishikawa T; Toyonaga T; Sakakida M; Araki E
Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia.
de Miguel V; Redal MA; Viale ML; Kahan M; Glerean M; Beskow A; Fainstein Day P
Medicina (B Aires); 2010; 70(3):254-6. PubMed ID: 20529775
[TBL] [Abstract][Full Text] [Related]
10. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension.
Lacroix A; Tremblay J; Touyz RM; Deng LY; Lariviere R; Cusson JR; Schiffrin EL; Hamet P
J Clin Endocrinol Metab; 1997 Aug; 82(8):2414-22. PubMed ID: 9253310
[TBL] [Abstract][Full Text] [Related]
11. Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates.
Louiset E; Contesse V; Groussin L; Cartier D; Duparc C; Perraudin V; Bertherat J; Lefebvre H
J Endocrinol; 2008 Jan; 196(1):1-9. PubMed ID: 18180312
[TBL] [Abstract][Full Text] [Related]
12. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds.
Gagliardi L; Hotu C; Casey G; Braund WJ; Ling KH; Dodd T; Manavis J; Devitt PG; Cutfield R; Rudzki Z; Scott HS; Torpy DJ
Clin Endocrinol (Oxf); 2009 Jun; 70(6):883-91. PubMed ID: 19018784
[TBL] [Abstract][Full Text] [Related]
13. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.
Nakamura Y; Son Y; Kohno Y; Shimono D; Kuwamura N; Koshiyama H; Sasano H; Matsuda T
Endocrine; 2001 Jun; 15(1):57-61. PubMed ID: 11572327
[TBL] [Abstract][Full Text] [Related]
14. Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors.
Vezzosi D; Cartier D; Régnier C; Otal P; Bennet A; Parmentier F; Plantavid M; Lacroix A; Lefebvre H; Caron P
Eur J Endocrinol; 2007 Jan; 156(1):21-31. PubMed ID: 17218722
[TBL] [Abstract][Full Text] [Related]
15. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome.
Bourdeau I; D'Amour P; Hamet P; Boutin JM; Lacroix A
J Clin Endocrinol Metab; 2001 Nov; 86(11):5534-40. PubMed ID: 11701732
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.
Assie G; Louiset E; Sturm N; René-Corail F; Groussin L; Bertherat J; Thomas M; Lefebvre H; Feige JJ; Clauser E; Chabre O; Cherradi N
J Clin Endocrinol Metab; 2010 Oct; 95(10):E253-62. PubMed ID: 20660048
[TBL] [Abstract][Full Text] [Related]
17. Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome.
Libé R; Coste J; Guignat L; Tissier F; Lefebvre H; Barrande G; Ajzenberg C; Tauveron I; Clauser E; Dousset B; Bertagna X; Bertherat J; Groussin L
Eur J Endocrinol; 2010 Jul; 163(1):129-38. PubMed ID: 20378721
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia.
Lee S; Hwang R; Lee J; Rhee Y; Kim DJ; Chung UI; Lim SK
Clin Endocrinol (Oxf); 2005 Dec; 63(6):625-30. PubMed ID: 16343095
[TBL] [Abstract][Full Text] [Related]
19. Improvement of hypercortisolism by β-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia.
Oki K; Yamane K; Nakanishi S; Nakashima R; Jitsuiki K; Kohno N
Endocrine; 2009 Dec; 36(3):372-6. PubMed ID: 19813002
[TBL] [Abstract][Full Text] [Related]
20. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide.
Iida K; Kaji H; Matsumoto H; Okimura Y; Abe H; Fujisawa M; Kamidono S; Chihara K
Clin Endocrinol (Oxf); 1997 Dec; 47(6):739-45. PubMed ID: 9497882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]